[Prognosis of internal diseases].

Internist (Berl)

Published: March 1981

Download full-text PDF

Source

Publication Analysis

Top Keywords

[prognosis internal
4
internal diseases]
4
[prognosis
1
diseases]
1

Similar Publications

Osteosarcoma (OS) is a commonly observed malignant tumor in orthopedics that has a very poor prognosis. The endosomal sorting complex required for transport (ESCRT) is important for the development and progression of cancer and may be a significant target for cancer therapy. First, we built a prognostic signature using 7 ESCRT-related genes (ERGs) to predict OS patient prognosis.

View Article and Find Full Text PDF

Background: The Clinical Frailty Scale (CFS) is a tool to assess the overall health of older adults. There are few reports of CFS and prognosis of ankle fracture. The objective of this study was to determine the predictive power of the CFS for adverse clinical and radiographic outcomes after surgery in elderly patients with trimalleolar fractures.

View Article and Find Full Text PDF

Background: During the COVID-19 pandemic, nursing home (NH) residents faced the highest risk of severe COVID-19 disease and mortality. Due to their frailty status, comorbidity burden can serve as a useful predictive indicator of vulnerability in this frail population. However, the prognostic value of these cumulative comorbidity scores like the Charlson comorbidity index (CCI) remained unclear in this population.

View Article and Find Full Text PDF

FMS-like tyrosine kinase-3 (FLT3), a class 3 receptor tyrosine kinase, can be activated by mutations of internal tandem duplication (FLT3-ITD) or point mutations in the tyrosine kinase domain (FLT3-TKD), leading to constitutive activation of downstream signaling cascades, including the JAK/STAT5, PI3K/AKT/mTOR and RAS/MAPK pathways, which promote the progression of leukemic cells. Despite the initial promise of FLT3 inhibitors, the discouraging outcomes in the treatment of FLT3-ITD-positive acute myeloid leukemia (AML) promote the pursuit of more potent and enduring therapeutic approaches. The histone acetyltransferase complex comprising the E1A binding protein P300 and its paralog CREB-binding protein (p300/CBP) is a promising therapeutic target, but the development of effective p300/CBP inhibitors faces challenges due to inherent resistance and low efficacy, often exacerbated by the absence of reliable clinical biomarkers for patient stratification.

View Article and Find Full Text PDF

Photobiomodulation therapy as an additional method for the treatment of temporomandibular disorder patients- a narrative review.

Lasers Med Sci

January 2025

Department of Internal Medicine, School of Clinical Medicine, Faculty of Health Sciences, WITS University, South Africa.

The photobiomodulation therapy (PBMT) is promising additional therapy in the treatment of temporomandibular disorder (TMD). In this regard, the purpose of this narrative review is to give a wide-ranging, objective, and judicious view of the current knowledge on PBMT as an additional TMD treatment modality, with summarised updated information. Although the results of most research studies report improvement of pain in TMD patients, some state that sustainability of absence of pain after PBMT of TMD is of concern.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!